Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Urology

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Pembrolizumab vs chemotherapy alone

Time to death from any cause (here: overall mortality at 12‐month

Pembrolizumab probably leads to lower time to death from any cause (here: overall mortality at 12‐month compared with chemotherapy (moderate certainty).

1 finding from 1 review

Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression… 2018 · Cochrane Headline outcomes only
HR 0.73 [0.59, 0.9]
1 study · 542 participants
Moderate